Re-treating chronic hepatitis C with daily interferon alfacon-1/ribavirin after nonresponse to pegylated interferon/ribavirin: really safe and effective?
- PMID: 19714721
- DOI: 10.1002/hep.23125
Re-treating chronic hepatitis C with daily interferon alfacon-1/ribavirin after nonresponse to pegylated interferon/ribavirin: really safe and effective?
Comment on
-
Retreating chronic hepatitis C with daily interferon alfacon-1/ribavirin after nonresponse to pegylated interferon/ribavirin: DIRECT results.Hepatology. 2009 Jun;49(6):1838-46. doi: 10.1002/hep.22871. Hepatology. 2009. PMID: 19291790 Clinical Trial.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources